Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Padmanabh Industries Ltd

PADMAIND
BSE
9.90
0.00%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Padmanabh Industries Ltd

PADMAIND
BSE
9.90
0.00%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
6Cr
Close
Close Price
9.90
Industry
Industry
Trading
PE
Price To Earnings
76.15
PS
Price To Sales
0.62
Revenue
Revenue
10Cr
Rev Gr TTM
Revenue Growth TTM
681.60%
PAT Gr TTM
PAT Growth TTM
-260.00%
Peer Comparison
How does PADMAIND stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
PADMAIND
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000010002007
Growth YoY
Revenue Growth YoY%
-435.7-100.0227.7308.30.0-100.02,471.4
Expenses
ExpensesCr
-100010002007
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-10.68.3-50.08.07.12.9-8.33.9
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
105.20.00.0-400.0-75.0-700.0200.0120.0600.075.0-2,000.02,100.0
NPM
NPM%
-8.51.7-66.74.03.62.9-16.73.1
EPS
EPS
0.10.00.0-0.10.0-0.10.00.00.10.0-0.30.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
0024000001310
Growth
Revenue Growth%
741.7125.0-100.0-100.0419.9215.5
Expenses
ExpensesCr
002500010139
Operating Profit
Operating ProfitCr
0000000-10000
OPM
OPM%
-56.0-6.3-9.3-519.9-3.61.53.0
Other Income
Other IncomeCr
00010-4-7-10000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000-5-7-20000
Tax
TaxCr
000000000000
PAT
PATCr
00000-5-7-20000
Growth
PAT Growth%
-34,151.9-33.572.01,734.8-155.3-3,573.7-59.078.799.9-3,776.3125.5447.9
NPM
NPM%
-22.8-0.85.5-1,162.9-9.60.50.8
EPS
EPS
-0.1-0.10.00.4-0.2-7.6-12.1-2.60.0-0.10.00.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
555666666666
Reserves
ReservesCr
000883-5-6-6-6-6-6
Current Liabilities
Current LiabilitiesCr
112122111130
Non Current Liabilities
Non Current LiabilitiesCr
000010111114
Total Liabilities
Total LiabilitiesCr
667151611322244
Current Assets
Current AssetsCr
1121121001141
Non Current Assets
Non Current AssetsCr
44441410310003
Total Assets
Total AssetsCr
667151611322244

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
00-1-81-3-8-1-10-3
Investing Cash Flow
Investing Cash FlowCr
0001-2381100
Financing Cash Flow
Financing Cash FlowCr
00191001003
Net Cash Flow
Net Cash FlowCr
0001-1000000
Free Cash Flow
Free Cash FlowCr
000-91-3-8-1-10-3
CFO To PAT
CFO To PAT%
79.059.04,484.9-3,683.9-523.757.5105.388.877,999.1-10.7-19,461.6
CFO To EBITDA
CFO To EBITDA%
80.624.0542.32,176.7-329.1767.13,698.3198.71,333.0-28.1-6,190.4

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
710225966532234
Price To Earnings
Price To Earnings
0.00.00.0257.50.00.00.00.00.00.0313.0
Price To Sales
Price To Sales
47.511.914.416.84.51.2
Price To Book
Price To Book
1.72.45.04.34.90.51.7-386.0-297.0-44.2-78.3
EV To EBITDA
EV To EBITDA
-204.3-85.9-195.1-151.7-332.1-13.5-15.0-4.1-27.8-151.2157.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.50.41.9-425.918.77.4
OPM
OPM%
-56.0-6.3-9.3-519.9-3.61.5
NPM
NPM%
-22.8-0.85.5-1,162.9-9.60.5
ROCE
ROCE%
-0.8-1.1-0.31.9-0.9-49.7-353.6-259.9-0.2-10.40.1
ROE
ROE%
-0.8-1.1-0.31.7-0.9-51.9-470.242,778.228.691.7-30.6
ROA
ROA%
-0.7-0.9-0.21.6-0.8-42.7-247.9-97.5-0.1-3.70.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Padmanabh Industries Limited is an Indian public entity listed on the **Bombay Stock Exchange (BSE)**. Historically rooted in the **Fabrics business**, the company is currently undergoing a fundamental strategic pivot. While its constitutional documents outline a broad mandate in **Specialty Chemicals** and **Pharmaceuticals**, its recent operational focus has shifted toward the **trading of Agriculture goods, Commodities, and Agri Materials**. The company operates under a **single reportable segment** model in accordance with **Ind AS**. Management has consolidated operations to function as a unified entity to streamline the ongoing business revival and financial reorganization. --- ### **Product Portfolio and Industrial Scope** The company’s operational framework encompasses the entire lifecycle of chemical and commodity trade, from manufacturing and refining to import-export and domestic distribution. | Segment | Core Activities | | :--- | :--- | | **Agri-Commodities** | Trading of agricultural goods and raw materials. | | **Dyes & Pigments** | Production and sale of synthetic and non-synthetic dyes for industrial applications. | | **Intermediates** | Manufacturing of **dye intermediates** and **coal-tar** derivatives. | | **Specialty Chemicals** | Production of **surface-active agents** (surfactants) and industrial chemicals. | | **Healthcare Inputs** | Manufacturing and dealing in **pharmaceutical** compounds and related inputs. | **Operational Capabilities:** * **Technical Processing:** Expertise in the **refining and manipulation** of raw chemical materials into value-added industrial outputs. * **Supply Chain Integration:** Integrated capabilities in **buying, importing, and exporting** across the chemical and agricultural sectors. --- ### **Capital Restructuring: The 98% "Balance Sheet Clean-up"** The defining feature of Padmanabh Industries' current strategy is a massive financial reorganization aimed at addressing historical **accumulated losses**. This "reset" is designed to align the company's capital structure with its actual asset value to facilitate fresh capital infusion. **The Scheme of Reduction of Capital:** Under **Section 66 of the Companies Act, 2013**, the company received shareholder approval on **September 30, 2024**, for a drastic capital reduction. | Metric | Pre-Reduction | Post-Reduction (Proposed/Final) | | :--- | :--- | :--- | | **Total Equity Shares** | **60,77,500** | **1,21,550** | | **Face Value per Share** | **Rs. 10** | **Rs. 10** | | **Paid-up Share Capital** | **Rs. 6,07,75,000** | **Rs. 12,15,500** | | **Capital Reduction %** | - | **98%** | | **Losses Written Off** | - | **Rs. 5,95,59,500** | * **Share Consolidation:** Shareholders receive **2 equity shares** for every **100 equity shares** previously held. * **Regulatory Status:** As of late **2025**, the final approval from the **National Company Law Tribunal (NCLT) Ahmedabad Bench** is in the process of being finalized. * **Strategic Goal:** Management believes this reduction is a prerequisite for attracting **Foreign Direct Investment (FDI)** and fresh funding, which was previously hindered by the loss-heavy balance sheet. --- ### **Financial Performance and Asset Management** The company’s financial profile has been characterized by extreme volatility and a total liquidation of inventory to settle obligations. **Comparative Financial Highlights (Rs. in Lakhs):** | Particulars | FY 2024-25 (As at 31st March) | FY 2023-24 (As at 31st March) | FY 2022-23 (As at 31st March) | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | - | **5,956.33** | **0.00** | | **Other Income** | - | **72.09** | **1,274.93** | | **Total Debts** | **350.83** | **60.99** | - | | **Total Equity** | **-4.77** | **-6.23** | - | | **Employee Benefit Expenses** | - | **270.01** | **486.00** | **Key Financial Observations:** * **Inventory Liquidation:** The company cleared its entire inventory of finished goods, which stood at **Rs. 4,841.29 Lakhs** at the start of **FY24**, resulting in **zero inventory** by the end of that cycle. * **Gearing and Liquidity:** The company reports a negative **Total Equity** of **Rs. 4.77 Lakhs** against **Total Debts** of **Rs. 350.83 Lakhs**. Capital management is currently focused exclusively on maintaining **"Going Concern"** status. * **Asset Base:** The company owns **no immovable properties**. It relies on an **annual physical verification** program for its existing Property, Plant, and Equipment. --- ### **Leadership and Governance Restructuring** To oversee the post-restructuring revival, the company underwent a comprehensive board overhaul in **2024 and 2025**. **Current Board Composition (as of August 2025):** * **Mr. Dhairya Bharatbhai Shah (Managing Director):** Appointed **July 23, 2025**, for a **5-year term**. He is tasked with leading the business development phase following the NCLT clearances. * **Mr. Umesh Parghi (CFO):** Assumed the role on **August 13, 2025**, to manage the restructured financial framework. * **Independent Oversight:** **Mr. Rahul Parmar** and **Mr. Harpalsinh Parmar** were appointed as **Independent Directors** in **July 2025** to ensure regulatory compliance during the transition. --- ### **Critical Risk Factors and Audit Qualifications** Investors should note significant "Material Weaknesses" identified in recent audits regarding internal controls and statutory compliance. **1. Regulatory and Tax Non-Compliance:** * **GST Inactivity:** The company’s **GST number has been inactive** for an extended period. No **GST returns** have been filed, making it impossible for auditors to verify reported **turnover** against statutory records. * **Audit Qualifications:** Auditors have expressed uncertainty regarding the **valuation and verification of Intangible Assets**, which may materially misstate the balance sheet. **2. Internal Control Deficiencies:** * **IT and Policy Gaps:** There is a lack of documented policies and inadequate **IT controls**, creating a risk of **management override**, collusion, or fraud. * **Risk Management:** The company lacks a formal **Risk Management Policy**, as management historically viewed business threats as minimal—a stance currently under scrutiny given the company's financial state. **3. Market and Operational Pressures:** * **Working Capital Intensity:** The legacy fabric and current trading businesses are highly **working capital intensive**. The company is sensitive to **interest rate hikes** and credit availability. * **Credit Risk:** The company faces significant exposure if counterparties fail to meet obligations, managed currently through **aging analysis** of receivables. * **Dependency on NCLT:** The entire growth thesis is contingent upon the successful legal execution of the **Capital Reduction** scheme. Failure to receive final orders would jeopardize the revival plan.